Join the leading experts of Migraine on Friday to get the recent updates in the management of Migraine highlighting on the role of Anti-CGRP monoclonal Antibodies in the new treatment paradigm.
1. Address the unmet need in prevention of Migraine and understand its impact on patients.
2. Understand the Real-World data on effectiveness, safety and tolerability of CGRPs in respect to the clinical trials.
3. Identify the appropriate patients for CGRP Monoclonal Antibodies.
FREE
Free